Literature DB >> 20607601

Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells.

Yuehan Wu1, Xun Guo, Yekaterina Brandt, Helen J Hathaway, Rebecca S Hartley.   

Abstract

The behavior of breast epithelial cells is influenced by their microenvironment which includes stromal cells and extracellular matrix (ECM). During cancer progression, the tissue microenvironment fails to control proliferation and differentiation, resulting in uncontrolled growth and invasion. Upon invasion, the ECM encountered by breast cancer cells changes from primarily laminin and collagen IV to primarily collagen I. We show here that culturing invasive breast cancer cells in 3-dimensional (3D) collagen I inhibits proliferation through direct regulation of cyclin E1, a G(1)/S regulator that is overexpressed in breast cancer. When the breast cancer cell line MDA-MB-231 was cultured within 3D collagen I gels, the G(1)/S transition was inhibited as compared to cells cultured on conventional 2D collagen or plastic dishes. Cells in 3D collagen downregulated cyclin E1 protein and mRNA, with no change in cyclin D1 level. Cyclin D1 was primarily cytoplasmic in 3D cultures, and this was accompanied by decreased phosphorylation of Rb, a nuclear target for both cyclin E1- and cyclin D1-associated kinases. Positive regulators of cyclin E1 expression, the transcription factor c-Myc and cold-inducible RNA binding protein (CIRP), were decreased in 3D collagen cultures, while the collagen I receptor β1 integrin was greatly increased. Inhibition of β1 integrin function rescued proliferation and cyclin E1 expression as well as c-Myc expression and Rb phosphorylation, but cyclin D1 remained cytoplasmic. We conclude that cyclin E1 is repressed independent of effects on cyclin D1 in a 3D collagen environment and dependent on β1 integrin interaction with collagen I, reducing proliferation of invasive breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607601      PMCID: PMC3635487          DOI: 10.1007/s10549-010-1013-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  47 in total

Review 1.  HuR and mRNA stability.

Authors:  C M Brennan; J A Steitz
Journal:  Cell Mol Life Sci       Date:  2001-02       Impact factor: 9.261

2.  Novel splice variants of cyclin E with altered substrate specificity.

Authors:  D C Porter; K Keyomarsi
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

Review 3.  Living with or without cyclins and cyclin-dependent kinases.

Authors:  Charles J Sherr; James M Roberts
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

4.  Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.

Authors:  C M Benaud; R B Dickson
Journal:  Oncogene       Date:  2001-07-27       Impact factor: 9.867

5.  Bovine type I collagen inhibits Raw264.7 cell proliferation through phosphoinositide 3-kinase- and mitogen-activated protein kinase-dependent down-regulation of cyclins D1, A and B1.

Authors:  Min Kyung Cho; Seung Hoon Suh; Chang Ho Lee; Sang Geon Kim
Journal:  Biochim Biophys Acta       Date:  2004-12-07

6.  Breast cancer by proxy: can the microenvironment be both the cause and consequence?

Authors:  Lone Rønnov-Jessen; Mina J Bissell
Journal:  Trends Mol Med       Date:  2008-12-16       Impact factor: 11.951

7.  Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.

Authors:  David A Solomon; Ying Wang; Sejal R Fox; Tah C Lambeck; Sarah Giesting; Zhengdao Lan; Adrian M Senderowicz; Claudio J Conti; Erik S Knudsen
Journal:  J Biol Chem       Date:  2003-05-12       Impact factor: 5.157

8.  Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.

Authors:  K J Sweeney; A Swarbrick; R L Sutherland; E A Musgrove
Journal:  Oncogene       Date:  1998-06-04       Impact factor: 9.867

9.  Cyclin E, a potential prognostic marker for breast cancer.

Authors:  K Keyomarsi; N O'Leary; G Molnar; E Lees; H J Fingert; A B Pardee
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

10.  Use of three-dimensional collagen gels to study mechanotransduction in T47D breast epithelial cells.

Authors:  Michele A Wozniak; Patricia J Keely
Journal:  Biol Proced Online       Date:  2005-10-17       Impact factor: 3.244

View more
  12 in total

Review 1.  Microenvironmental control of the breast cancer cell cycle.

Authors:  Xun Guo; Yuehan Wu; Helen J Hathaway; Rebecca S Hartley
Journal:  Anat Rec (Hoboken)       Date:  2012-01-24       Impact factor: 2.064

2.  Identification of key genes and pathways in uterine leiomyosarcoma through bioinformatics analysis.

Authors:  Yuqin Zang; Lina Gu; Yanfang Zhang; Yingmei Wang; Fengxia Xue
Journal:  Oncol Lett       Date:  2018-04-16       Impact factor: 2.967

3.  A 3D in situ cell counter reveals that breast tumor cell (MDA-MB-231) proliferation rate is reduced by the collagen matrix density.

Authors:  Beum Jun Kim; Shuting Zhao; Rodica P Bunaciu; Andrew Yen; Mingming Wu
Journal:  Biotechnol Prog       Date:  2015-03-01

4.  Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analyses.

Authors:  Xu Zhou; Hua-Qiang Zhu; Jun Lu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

5.  An Evaluation of Matrix-Containing and Humanised Matrix-Free 3-Dimensional Cell Culture Systems for Studying Breast Cancer.

Authors:  Grace C Roberts; Paul G Morris; Marcus A Moss; Sarah L Maltby; Chelsea A Palmer; Claire E Nash; Emily Smart; Deborah L Holliday; Valerie Speirs
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

6.  Down-regulation of α-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surface.

Authors:  Tzu-Chun Cheng; Shih-Hsin Tu; Li-Ching Chen; Ming-Yao Chen; Wen-Ye Chen; Yen-Kuang Lin; Chi-Tang Ho; Shyr-Yi Lin; Chih-Hsiung Wu; Yuan-Soon Ho
Journal:  Oncotarget       Date:  2015-08-28

7.  mDia1 regulates breast cancer invasion by controlling membrane type 1-matrix metalloproteinase localization.

Authors:  Daehwan Kim; Jangho Jung; Eunae You; Panseon Ko; Somi Oh; Sangmyung Rhee
Journal:  Oncotarget       Date:  2016-04-05

8.  Overexpression of β1 integrin contributes to polarity reversal and a poor prognosis of breast invasive micropapillary carcinoma.

Authors:  Bingbing Liu; Xia Zheng; Fanfan Meng; Yunwei Han; Yawen Song; Fangfang Liu; Shuai Li; Lanjing Zhang; Feng Gu; Xinmin Zhang; Li Fu
Journal:  Oncotarget       Date:  2017-11-30

9.  Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway.

Authors:  S Han; Z Li; L M Master; Z W Master; A Wu
Journal:  Br J Cancer       Date:  2014-08-05       Impact factor: 7.640

Review 10.  Cold-inducible proteins CIRP and RBM3, a unique couple with activities far beyond the cold.

Authors:  Xinzhou Zhu; Christoph Bührer; Sven Wellmann
Journal:  Cell Mol Life Sci       Date:  2016-05-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.